Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial

Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine

NCT00600093 ·Status: TERMINATED ·Phase: PHASE2

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

NCT05116813 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications

NCT01960842 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease

NCT01048229 ·Status: TERMINATED ·Phase: PHASE4

The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1

NCT07217665 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

NCT00203164 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

NCT00203060 ·Status: COMPLETED ·Phase: PHASE3

Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease

NCT01032486 ·Status: COMPLETED

An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)

NCT01215227 ·Status: TERMINATED ·Phase: PHASE3

An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications

NCT02082249 ·Status: COMPLETED ·Phase: PHASE3

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

NCT00203034 ·Status: COMPLETED ·Phase: PHASE3

Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)

NCT01227265 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease

NCT06195124 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Rasagiline for Gait Treatment

NCT01098396 ·Status: UNKNOWN

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline

NCT01879748 ·Status: COMPLETED ·Phase: PHASE1

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

NCT04857359 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

NCT01336088 ·Status: COMPLETED ·Phase: PHASE2

AB-1005 Long-Term Follow-up Study

NCT07081841 ·Status: ENROLLING_BY_INVITATION

ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)

NCT04831281 ·Status: TERMINATED ·Phase: PHASE2

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

NCT00399477 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

NCT04995081 ·Status: COMPLETED ·Phase: PHASE2

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

NCT00203177 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor

NCT02668146 ·Status: UNKNOWN ·Phase: PHASE2

Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist

NCT01338662 ·Status: UNKNOWN

A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

NCT00256204 ·Status: COMPLETED ·Phase: PHASE3